Drreddys Laboratories | RDY - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
ANI Pharmaceuticals USD 311.18M 25.59M 2026-03
Aurora Cannabis CAD 56.36M 39.33M 2025-12
Bayer EUR 6.67B 774M 2025-12
Canopy Growth CAD 371.32M 73.26M 2025-12
Cipla INR 7.96B 39.9M 2025-09
Corcept Therapeutics USD 108.74M 11.76M 2026-03
Drreddys Laboratories INR 18.66B 9.65B 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Hikma Pharmaceutical USD 236M 48M 2025-06
Lonza CHF 719M 188M 2025-12
Novartis USD 6.88B 4.56B 2026-03
Pacira USD 144.31M 14.24M 2026-03
Phibro Animal Health USD 54.93M 557K 2026-03
Prestige Brands USD 63.87M 1.5M 2026-03
Richter Gedeon HUF 135.63B 61.59B 2024-12
Sun Pharmaceuticals INR 113.32B 33.19B 2025-03
Supernus Pharmaceuticals USD 184.87M 56.42M 2026-03
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12